Category - Feature

Feature

Alto disrupting the trial-and-error approach to treating neuropsychiatric disorders

By Melane Sampson Amit Etkin, MD, PhD, founder, president, and CEO of Alto Neuroscience Alto Neuroscience (NYSE: ANRO) is aiming to redefine the way neuropsychiatric conditions are treated through a biology-driven...

August 4, 2026

Feature

In conversation with Jen Sharpe, partner, advisory services, at IntegriChain, and founder of the Revenue Analytics Collaboration

A pharmaceutical and life sciences technology, data, and consulting platform, IntegriChain delivers solutions that help companies manage the commercial and financial complexities of bringing therapies to market...

July 21, 2026

Feature

Adaptin Bio is leveraging immune cell hitchhiking to target brain tumors

Adaptin Bio (OTCQB: APTN) is advancing a novel strategy to overcome one of the most persistent challenges in neuro-oncology—delivering effective therapies across the blood-brain barrier. By leveraging the natural...

July 14, 2026

Feature

Senti Biosciences outsmarting complex disease with next-gen cell and gene therapies

Senti Biosciences (NASDAQ: SNTI) is developing a new generation of cell and gene therapies designed to bring greater precision, control, and safety to the treatment of difficult-to-treat cancers and other incurable...

July 7, 2026

Feature

OS Therapies aims to activate the immune system to combat aggressive cancers in human and canine patients

OS Therapies (NYSE American: OSTX) is addressing the urgent need for innovative therapies to kill aggressive cancers that express HER2, including osteosarcoma—a rare and often fatal bone cancer—as well as other solid...

June 16, 2026

Feature

Healing the Hero rewiring trauma through neurolinguistic programming

The nonprofit organization Healing the Hero is bringing hope to U.S. military personnel, veterans, first responders, and Gold Star Families by leveraging neurolinguistic programming (NLP)-informed methods to directly...

June 9, 2026

Feature

Siloton further unlocking the power of OCT imaging with a groundbreaking photonic chip

Closely held Siloton is developing a patented miniaturized medical imaging platform that combines photonic chips with optical coherence tomography (OCT) to detect and monitor a range of prevalent ophthalmic diseases...

June 2, 2026

Feature

Pacylex reshaping cancer treatment with a novel once-daily oral therapy

Closely held Pacylex Pharmaceuticals is developing a first-in-class oral cancer therapy with a novel, broad mechanism of action designed for refractory cancers as both a monotherapy and a future combination therapy.

May 26, 2026

Feature

illumiSonics expanding the limits of tissue imaging with a single scan

Closely held illumiSonics is addressing a significant unmet medical need by redefining tissue imaging with its proprietary multi-laser imaging (MLI) platform, an advanced modality designed for life sciences research...

May 19, 2026

Feature

Adagio delivering first-of-its-kind innovation in cardiac ablation technology

Adagio Medical (NASDAQ: ADGM) is innovating catheter ablation technologies for the treatment of one of the most challenging and underserved areas in electrophysiology—ventricular tachycardia (VT), a dangerous type of...

May 5, 2026

Category - Feature

Subscribe